Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068989 · ClinicalTrials.gov registry record
Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02068989 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 1 participants.
The verdict
NCT02068989 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068989
The ClinicalTrials.gov registry entry for NCT02068989 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02068989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068989 about?
NCT02068989 is a clinical study titled "Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus". We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn t...
What is the current status of trial NCT02068989?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2013-02. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02068989?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.